|
|
|
Insider
Information: |
Crowley John F |
Relationship: |
Director |
City: |
Cranbury |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
590,194 |
|
Indirect Shares
|
97,759 |
|
|
Direct
Value |
$6,391,209 |
|
|
Indirect Value
|
$688,536 |
|
|
Total
Shares |
687,953 |
|
|
Total
Value |
$7,079,745 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amicus Therapeutics Inc |
FOLD |
|
2024-03-01 |
573,478 |
2024-03-01 |
64,895 |
Premium* |
|
Intellia Therapeutics, Inc. |
NTLA |
Director |
2023-06-14 |
11,716 |
2021-06-23 |
0 |
Premium* |
|
Entrada Therapeutics, Inc. |
TRDA |
Director |
2022-01-12 |
5,000 |
2022-01-12 |
32,864 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
298 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FOLD |
Amicus Therapeutics Inc |
President & CEOOfficer |
|
2007-05-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
146,666 |
|
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Director |
|
2021-10-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
32,864 |
|
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2020-06-15 |
4 |
D |
$11.14 |
$1,816 |
D/D |
(163) |
900,023 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2019-06-17 |
4 |
D |
$11.35 |
$2,327 |
D/D |
(205) |
750,194 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President and CEO |
|
2008-01-02 |
4 |
AS |
$10.35 |
$4,140 |
D/D |
(400) |
68,734 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-12-21 |
4 |
AS |
$13.51 |
$6,836 |
D/D |
(506) |
328,001 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-12-21 |
4 |
OE |
$13.51 |
$6,836 |
D/D |
506 |
358,507 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President & CEO |
|
2009-03-11 |
4 |
OE |
$5.33 |
$5,325 |
D/D |
1,000 |
119,736 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President and CEO |
|
2008-06-02 |
4 |
AS |
$10.12 |
$13,250 |
I/I |
(1,300) |
34,300 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-09-26 |
4 |
B |
$14.36 |
$20,032 |
D/D |
1,395 |
328,001 |
2.81 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President & CEO |
|
2008-10-01 |
4 |
AS |
$15.08 |
$21,113 |
I/I |
(1,400) |
14,600 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President and CEO |
|
2008-07-03 |
4 |
AS |
$10.73 |
$16,245 |
I/I |
(1,500) |
26,200 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President and CEO |
|
2008-04-03 |
4 |
AS |
$11.00 |
$19,836 |
I/I |
(1,800) |
40,000 |
0 |
- |
|
NTLA |
Intellia Therapeutics, In... |
Director |
|
2021-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,094 |
2,094 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President and CEO |
|
2008-07-07 |
4 |
AS |
$10.69 |
$24,489 |
I/I |
(2,200) |
25,200 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2022-04-18 |
4 |
AS |
$8.04 |
$17,794 |
D/D |
(2,214) |
974,221 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President & CEO |
|
2008-10-06 |
4 |
AS |
$14.75 |
$33,937 |
I/I |
(2,300) |
10,200 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President and CEO |
|
2008-04-01 |
4 |
AS |
$10.83 |
$26,676 |
I/I |
(2,400) |
43,800 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President & CEO |
|
2008-09-03 |
4 |
AS |
$13.75 |
$34,411 |
I/I |
(2,500) |
17,700 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President and CEO |
|
2008-09-04 |
4 |
AS |
$13.83 |
$34,599 |
I/I |
(2,500) |
16,400 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President and CEO |
|
2008-09-05 |
4 |
AS |
$13.74 |
$34,356 |
I/I |
(2,500) |
15,200 |
0 |
- |
|
NTLA |
Intellia Therapeutics, In... |
Director |
|
2021-10-11 |
4 |
AS |
$119.55 |
$298,875 |
D/D |
(2,500) |
2,094 |
0 |
% |
|
NTLA |
Intellia Therapeutics, In... |
Director |
|
2021-10-11 |
4 |
OE |
$18.83 |
$47,075 |
D/D |
2,500 |
4,594 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President & CEO |
|
2008-09-02 |
4 |
AS |
$13.75 |
$35,838 |
I/I |
(2,600) |
18,900 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President & CEO |
|
2008-10-02 |
4 |
AS |
$15.06 |
$39,251 |
I/I |
(2,600) |
13,300 |
0 |
- |
|
298 Records found
|
|
Page 1 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|